Margarita M. Urumova

Margarita M. Urumova

Auto-generated profile, based on publicly available information

Margarita M. Urumova

V.A. Nasonova Research Institute of Rheumatology

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2022 in Rheumatology Science and Practice
Verified
Journal Article
Open access
PDF file
ЕГЕ. Е. Губарь
Е. Е. Губарь
TKT. V. Korotaeva
T. V. Korotaeva
YKYu. L. Korsakova
Yu. L. Korsakova
ELE. Yu. Loginova
E. Yu. Loginova
ASA. V. Smirnov
A. V. Smirnov
SGSvetlana Glukhova
Svetlana Glukhova
Objective: to evaluate clinical and instrumental characteristics of axial lesion in psoriatic arthritis (PsA) in real-life clinical practice.Subjects and methods. Examination were made in 52 patients (32 men and 20 women) with back pain recorded either at the time of their admission or in their medical histories. The inflammatory back pain (IBP) was diagnosed according to the Assessment of SpondyloArthritis international Society (ASAS) criteria. Back pain lasting over three months without meeting the ASAS criteria was taken to be chronic back (chrBP). Hands, feet, pelvis, cervical spine (CSP) and lumbar spine (LSP) were X-rayed. Erosions, osteolysis, and periarticular osteo-proliferative lesions were evaluated applying PsA-modified Sharp/van der Heijde score (SHS). Sacroiliitis (SI) was considered radiologically significant (r-sSI) when it was bilateral grade II or higher, or unilateral grade III or higher by Kellgren. 15 patients without r-sSI had their sacroiliac joints (SIJs) scanned using magnetic resonance imaging (MRI). Syndesmophytes, paravertebral ossifications, constriction and ankylosis of the CSP zygapophysial joints were considered to be radiological signs of psoriatic spondylitis. HLA-B27 typing was performed in 45 patients.Results and discussion. IBP was identified in 34 (66.7%), chrBP in 17 (33.3%) patients; 15 patients (28.8%) were of advanced age (over 40) at the onset of IBP/chrBP; 30 cases (57.7%) had r-sSI; in 18 cases SI was not detected. 13 out of 30 r-sSI patients (43.3%) didn’t suffer IBP. Erosions were detected in 38 (76%) patients, osteolysis in 13 (26%) and osteo-proliferative lesions in 18 (36%) patients. Average SHS was 82.79±64.77 correlating with the presence of r-sSI (r=0,46; p˂ 0,05). Correlation of r=0.35 was found between r-sSI and the spine limited mobility according to Bath Ankylosing Spondylitis Metrology Index (BASMI); r-sSI was detected with much higher statistical significance in the presence of periarticular osteo-proliferative lesions than in the absence of such (р=0.02). In PsA patients having periarticular osteolysis, axial lesion in the form of asymmetric syndesmophytes was detected ten times more frequently than in those not having it (OR=10; 95% CI: 1.63–61.327). In CSP, syndesmophytes developed two times more frequently than in LSP (p=0.01). Discrete CSP lesions in the absence of any LSP changes was observed in 30% of cases. SI was MRI detected in 2 (13.3%) patients. In 9 (18.0%) patients axial lesions were observed without SI. 15 patients (33.3%) were HLA-B27 positive. A set of specific PsA axial skeletal involvement features were revealed: possibility of oligosymptomatic clinical presentation; patient’s advanced age at the back pain onset; association with severe destructive peripheral arthritis; and more pronounced CSP lesions as compared to LSP. An alternative phenotype patient group (18%) without X-ray or MRI SI but with spine involvement was identified.

28 April 2024 in Rheumatology Science and Practice
Verified
Journal Article
Open access
PDF file
ЕГЕ. Е. Губарь
Е. Е. Губарь
ТKТ. V. Korotaeva
Т. V. Korotaeva
ТDТ. V. Dubinina
Т. V. Dubinina
LVL. D. Vorobyeva
L. D. Vorobyeva
РTР. О. Tremaskina
Р. О. Tremaskina
SGSvetlana Glukhova
Svetlana Glukhova
Objective – to compare clinical characteristics of patients with axial spondyloarthritis (axSpA)/ankylosing spondylitis (AS) and with axial psoriatic arthritis (axPsA).Subjects and methods. 100 patients were examined: 45 – with axSpA/AS (group 1), 55 – with axPsA (group 2). Patients of group 1 were included according to axSpA/AS criteria, patients of group 2 – according to CASPAR (ClASsification criteria for Psoriatic ARthritis) criteria, and having axial involvement (axPsA). Axial involvement was detected in case of radiologically significant sacroiliitis (bilateral grade ≥2 or unilateral grade ≥3) or active MRI sacroiliitis, or ≥1 syndesmophyte(s) of the cervical and/or lumbar spine. Patients were evaluated for presence of inflammatory back pain (IBP) by ASAS (Assessment of Spondyloarthritis International Society) criteria.Results and discussion. Patients of group 1 were younger (p<0.001), more often HLA-B27 positive (p40 years) at back pain onset (p<0.001), more often peripheral arthritis (p<0.001), dactylitis (p=0.004), and skin psoriasis (p<0.001). Nail psoriasis was found only in group 2 patients (p<0.001). Group 1 patients had more often heel enthesitis (p=0.005). Group 2 patients had worse axial disease activity scores: BASDAI (Bath Ankylosing Spondylitis Disease Activity Index; p=0.006) and ASDAS-СRP (Ankylosing Spondylitis Disease Activity Score with C-reactive protein level determination; р<0.001); and worse patient reported outcomes: BASFI (Bath Ankylosing Spondylitis Functional Index; p=0.004), patients’ pain (p=0.005) and patients’ global assessments (p=0.036). Patients of group 2 had more syndesmophytes of the lumbar (р=0.009) and cervical (р=0.007) spine. Only in group 2 patients, chunky “non-marginal” syndesmophytes were found (in 32.1%), as well as spinal lesions without sacroiliitis (in 20.0%). Patients of group 2 had more joint erosions (р=0.001), osteolysis (р=0.015), juxta-articular bone formation (р<0.001) and joint ankyloses (р=0.02). All patients of group 1 and only 80% of group 2 (р=0.003) met ASAS criteria for axSpA. AxSpA/AS and axPsA seem to be two different diseases. In our cohort of patients, axPsA patients had worse disease status compared to axSp and AS.

24 June 2025 in Modern Rheumatology Journal
Verified
Journal Article
Open access
PDF file
ЕГЕ. Е. Губарь
Е. Е. Губарь
TKT. V. Korotaeva
T. V. Korotaeva
TDT. V. Dubinina
T. V. Dubinina
YKYu. L. Korsakova
Yu. L. Korsakova
ELE. Yu. Loginova
E. Yu. Loginova
SGSvetlana Glukhova
Svetlana Glukhova
Objective: To analyze clinical and imaging characteristics of patients with axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) with spinal involvement (axial PsA, axPsA) and to develop principles for the differential diagnosis between axPsA and axSpA.Material and methods. A total of 222 patients were examined: 108 with axSpA (Group 1) and 114 with axPsA (Group 2). Group 1 included patients meeting the criteria for axSpA/ankylosing spondylitis (AS); Group 2 included patients meeting the CASPAR criteria for PsA with axial involvement. Axial involvement was defined as radiographically confirmed (rc) sacroiliitis (SI; bilateral SI ≥ grade II or unilateral SI ≥ grade III), active SI on MRI, or ≥1 syndesmophyte in the cervical (CS) and/or lumbar (LS) spine. Inflammatory back pain (IBP) was assessed using ASAS criteria.Results and discussion. Patients in Group 1 were younger (p<0.001), more frequently HLA-B27 positive (p40 years) was more common (p<0.001), along with peripheral arthritis (p<0.001), dactylitis (p=0.004), and skin psoriasis (p<0.001). Nail psoriasis was observed exclusively in Group 2 (p<0.001). Heel enthesitis was more frequent in Group 1 (p<0.001). Patients in Group 2 had higher BASDAI scores (p<0.001) and more often had high ASDAS-CRP disease activity (p<0.001). They also had higher BASFI scores (p=0.008), pain scores (p=0.002), and patient global assessment (p=0.021).rcSI and sacroiliac joint ankylosis were more common in Group 1 (p=0.03 and p=0.006, respectevly). Group 2 more frequently exhibited syndesmophytes in the LS (p<0.001) and CS (p=0.004), as well as bulky (p<0.001), asymmetric (p=0.006), and non-bridging (p<0.001) syndesmophytes. Vertebral changes in the absence of SI (p<0.001), higher mSASSS scores (p<0.001), and more frequent erosions of hand and foot joints, multiple erosions, osteolysis, juxta-articular new bone formation (p<0.001 for all), and joint ankylosis (p=0.008) were also observed in Group 2, along with elevated CRP levels (p=0.002).Conclusion: This study revealed several genetic, demographic, clinical, and imaging differences that collectively enable the differential diagnosis between axSpA/AS and axPsA.

15 May 2021 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
DRDaria G. Rumiantceva
Daria G. Rumiantceva
MUMargarita M. Urumova
Margarita M. Urumova
SEShandor F. Erdes
Shandor F. Erdes
РГРумянцева Дарья Гаврильевна
Румянцева Дарья Гаврильевна
The novel coronavirus infection COVID-19 (SARS-CoV-2) is now known to cause a variety of extrapulmonary complications, including cardiovascular, neurological and dermatological complications, many of which occur or last several weeks after infection. We present a clinical case of a patient who first developed symptoms of ankylosing spondylitis 2 weeks after recovering from COVID-19. The patient was prescribed therapy in accordance with international and Russian recommendations for the management of patients with ankylosing spondylitis with a positive effect in the form of absence arthritis, enthesitis and reducing the inflammatory back pain.

24 June 2021 in Modern Rheumatology Journal
Verified
Journal Article
Open access
PDF file
RBR. M. Balabanova
R. M. Balabanova
EIE. V. Ilyinykh
E. V. Ilyinykh
MPM. V. Podryadnova
M. V. Podryadnova
SGSvetlana Glukhova
Svetlana Glukhova
MUM. M. Urumova
M. M. Urumova
Over the past decades, there has been an increase in the incidence of asymptomatic hyperuricemia (AHU), which includes an increased level (>360 μmol/L) of uric acid (UA) in the blood serum of patients with no clinical manifestations of gout. AHU is reported in various rheumatic diseases, mainly in osteoarthritis, in which AHU is one of the manifestations of the metabolic syndrome. There is relationship between AHU and pulmonary hypertension in systemic sclerosis, arterial hypertension (AH) in men with seronegative rheumatoid arthritis, extensive cutaneous psoriasis and metabolic disorders in psoriatic arthritis. There are almost no data on AHU in ankylosing spondylitis (AS), which served objective for this work.Objective: to assess the association of AHU with AS duration and activity and the presence of comorbid diseases.Patients and methods. A retrospective analysis of 48 medical histories of patients with diagnosed AS, who were treated in V.A. Nasonova Research Institute of Rheumatology from 2015 to 2019 years, whose serum UA level was >360 μmol/L.Results and discussion. More than half of patients with AS and AHU were overweight, 21% were obese. AH was diagnosed in 43.7% of patients. Stage II–III chronic kidney disease was detected in 16.7% of patients, urolithiasis – in 18.8%. 4 (8.3%) patients had diabetes mellitus. The serum UA level in patients with AS was 422.0 ± 61.6 μmol/L. In patients with AS, an association between AHU and age, duration and disease activity was noted. There was no statistically significant rela- tionship between HG and blood glucose, cholesterol, creatinine levels, body mass index. Correlation analysis revealed a statistically significant relationship between the glomerular filtration rate (GFR) and the age of patients (r=-0.54, p<0.001), the duration of the disease (r=-0.40, p<0.05), cholesterol level (r=-0.48, p=0.01), UA level (r=-0.45, p=0.03) and blood pressure (r=-0.54, p0.05).Conclusion. In AS, an association between an increased level of UA in the blood serum and the duration and activity of the disease, and patient's age, was established.

2 March 2025 in Rheumatology Science and Practice
Verified
Journal Article
Open access
PDF file
ЕГЕ. Е. Губарь
Е. Е. Губарь
TKT. V. Korotaeva
T. V. Korotaeva
LVL. D. Vorobyeva
L. D. Vorobyeva
ELE. Yu. Loginova
E. Yu. Loginova
YKYu. L. Korsakova
Yu. L. Korsakova
SGSvetlana Glukhova
Svetlana Glukhova
The aim – to develop a unified diagnostic algorithm for axial psoriatic arthritis (axPsA).Subjects and methods. 122 patients with psoriatic arthritis (PsA), duration less than 10 years, were included in the study according to CASPAR (The ClASsification for Psoriatic ARthritis) criteria, provided they also had axial involvement. Axial involvement was detected in case of radiographic sacroiliitis ((rSI); bilateral grade ≥2 or unilateral grade ≥3) or SI active according to magnetic resonance imaging (MRI) (MRI-SI), or ≥1 syndesmophyte(s) of the cervical and/or lumbar spine (CS/LS), or facet joints ankyloses of the CS. Patients were evaluated for the presence of inflammatory back pain (IBP) by ASAS (The Assessment of SpondyloArthritis international Society) criteria. Back pain lasting over three months, that did not meet ASAS criteria was considered chronic back pain (chrBP). HLA-B27 antigen status was observed.Results and discussion. IBP was identified in 87 (71.3%), chrBP – in 35 (28.7%) patients, 49 (40.2%) patients had older age (>40 years) at back pain onset. 120 (98.4%) patients had peripheral arthritis, 75 (61.5%) – dactylitis, 69 (56.6%) – enthesitis, 122 (100%) – psoriasis, 90 (73.8%) – nail psoriasis. Isolated axial disease without peripheral arthritis was found in 2 (1.6%) patients. RSI was detected in 85 (69.7%) patients, in 28 of 85 (32.9%) patients rSI developed without IBP. Spinal lesions of the LS and CS were found in 100 (82.0%) patients, chunky “non-marginal” syndesmophytes – in 60 (49.2%), asymmetrical syndesmophytes of the LS – in 22 of 72 (30.6%), paravertebral ossification – in 5 (4.1%) patients. Isolated spinal lesions without rSI were found in 37 (30.3%), isolated spinal lesions without rSI or MRI-SI – in 21 (17.2%) patients. HLA-B27 was observed in 27 of 86 (31.4%) examined patients. Diagnostic algorithm for axPsA was developed. All PsA patients, regardless whether they experienced IBP/chrBP or not, must undergo diagnostic imaging: pelvis, LS and CS X-ray. In patients without rSI, MRI of the sacroiliac joints should be performed. AxPsA diagnosis must be confirmed by imaging. Axial involvement is detected in case of rSI or MRI-SI, or ≥1 syndesmophyte(s) of the CS/LS, or facet joints ankyloses of the CS.